Skip to main content
. Author manuscript; available in PMC: 2010 May 1.
Published in final edited form as: Clin Immunol. 2009 Jan 25;131(2):260–270. doi: 10.1016/j.clim.2008.12.001

Figure 6. Diabetogenicity of adoptively transferred T cells is inhibited in GM-CSF-treated NOD-Scid mice.

Figure 6

Six-week-old female NOD scid mice (n=5/group) were either treated with GM-CSF as indicated in methods or left untreated (naïve). These mice received CD4+CD25- or CD4+ T cells (2×106/mouse) from 8-week-old female NOD mice. T cell recipients were bled weekly for monitoring blood glucose levels and considered diabetic when it remained above 250 mg/dL for 2 consecutive weeks. Log-rank test was carried out to determine statistical significance.